Multiple myeloma (MM) is an incurable B-cell malignancy, but with the emergence of immunotherapy, a potential cure is hopeful.

Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.

Immunosequencing has emerged as a newer clinical test for assessment of T cell clonality in the blood and skin of cutaneous T-cell lymphoma (CTCL)...

The complexity of their molecular composition and the variability in clinical presentation make clinical diagnosis and treatment selection a serious...

Multiple myeloma (MM) is a cancer of plasma cells. Normal (NL) cells are considered to pass through a precancerous state, such as monoclonal...

Primary anaplastic-lymphoma-kinase (ALK)-positive large-cell lymphoma of the central nervous system (PCNS ALK-positive ALCL) is a rare entity, with a...

A retrospective study involving review of 71 medical records of patients diagnosed with Hodgkin's Lymphoma between February 2012 and January 2016 was...

Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune...

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and...

Primary gastrointestinal (GI) T- and NK- cell lymphomas / lymphoproliferative disorders (LPD) are uncommon and they are usually aggressive in nature.

To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin’s Lymphoma treated at the...

Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype and multiple myeloma: a case...